Use TCS if no response to basic skin care 1 2 consider pt age body area degree of xerosis pt preference cost when selecting TCS 2 3 typically lower potency in areas of thin skin face neck genitals skin folds 1 3 qd application may be as effective as bid 2 Submitted by vgreene on Thu, 06/16/2022 - 10:50 Read more about Use TCS if no response to basic skin care 1 2 consider pt age body area degree of xerosis pt preference cost when selecting TCS 2 3 typically lower potency in areas of thin skin face neck genitals skin folds 1 3 qd application may be as effective as bid 2
Basic skin care liberal use of moisturizers1 2 esp applied soon after bathing 2 3 avoidance of aggravating factors eg long hot baths showers irritants such as soaps cleansers fragrances wool etc 1 3 Submitted by vgreene on Thu, 06/16/2022 - 10:49 Read more about Basic skin care liberal use of moisturizers1 2 esp applied soon after bathing 2 3 avoidance of aggravating factors eg long hot baths showers irritants such as soaps cleansers fragrances wool etc 1 3
Basic skin care plus topical anti inflammatories improve sx and reduce flares Submitted by vgreene on Thu, 06/16/2022 - 10:49 Read more about Basic skin care plus topical anti inflammatories improve sx and reduce flares
Assess severity Available dz severity QoL scales not recommended for routine clinical use ask about itch sleep impact on daily activity dz persistence instead1 Submitted by vgreene on Thu, 06/16/2022 - 09:26 Read more about Assess severity Available dz severity QoL scales not recommended for routine clinical use ask about itch sleep impact on daily activity dz persistence instead1
Serum IgE not reliable for definitive dx total or allergen specific serum IgE positive in most pts w AD2 80 per AAD 1 but allergen specific levels also positive in 55 of gen population 1 levels vary w severity 1 2 but false positives limit utility so don Submitted by vgreene on Thu, 06/16/2022 - 09:25 Read more about Serum IgE not reliable for definitive dx total or allergen specific serum IgE positive in most pts w AD2 80 per AAD 1 but allergen specific levels also positive in 55 of gen population 1 levels vary w severity 1 2 but false positives limit utility so don
Other tests not routine skin bx serum IgE KOH prep patch testing and or genetic testing may be helpful to r o other associated skin conditions1 or to identify triggers2 Submitted by vgreene on Thu, 06/16/2022 - 09:24 Read more about Other tests not routine skin bx serum IgE KOH prep patch testing and or genetic testing may be helpful to r o other associated skin conditions1 or to identify triggers2
Features supporting dx early age onset 60 by age 1y 80 90 by age 5y 1 2 PMH or FHx of atopy hx of IgE reactivity1 Submitted by vgreene on Thu, 06/16/2022 - 09:22 Read more about Features supporting dx early age onset 60 by age 1y 80 90 by age 5y 1 2 PMH or FHx of atopy hx of IgE reactivity1
Rash distribution changes w age face neck extensor surfaces common in infants young kids 1 2 flexural lesions occur at any age 1 but localized lichenified flexural lesions more common in older kids adults 2 spares groin axillae1 Submitted by vgreene on Thu, 06/16/2022 - 09:21 Read more about Rash distribution changes w age face neck extensor surfaces common in infants young kids 1 2 flexural lesions occur at any age 1 but localized lichenified flexural lesions more common in older kids adults 2 spares groin axillae1
Essential hallmark features pruritis scratching chronic or relapsing or both eczematous lesions 1 2 common lesion findings erythema edema erosions excoriations oozing lichenification1 3 Submitted by vgreene on Thu, 06/16/2022 - 09:21 Read more about Essential hallmark features pruritis scratching chronic or relapsing or both eczematous lesions 1 2 common lesion findings erythema edema erosions excoriations oozing lichenification1 3
Dx based on hx clinical signs skin lesion morphology No reliable biomarkers for dx Dz severity informs tx decisions Submitted by vgreene on Thu, 06/16/2022 - 09:20 Read more about Dx based on hx clinical signs skin lesion morphology No reliable biomarkers for dx Dz severity informs tx decisions
